Skip to main content

Lord, Abbett & Co. LLC

SEC CIK
0000728100
Latest filing
Aug 14, 2026

KRTX holding history

Karuna Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRTX overviewAll 13F holders of KRTXFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of KRTX by Lord, Abbett & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−139,618−100.0%Sold outHolders
Q3 2023139,618$23.6M0.1%−434,988−75.7%ReducedHolders
Q2 2023574,606$124.6M0.4%+83,464+17.0%AddedHolders
Q1 2023491,142$89.2M0.3%−57,179−10.4%ReducedHolders
Q4 2022548,321$107.7M0.4%−146,457−21.1%ReducedHolders
Q3 2022694,778$156.3M0.6%+412,548+146.2%AddedHolders
Q2 2022282,230$35.7M0.1%−87,315−23.6%ReducedHolders
Q1 2022369,545$46.9M0.1%+127,840+52.9%AddedHolders
Q4 2021241,705$31.7M0.1%−69,911−22.4%ReducedHolders
Q3 2021311,616$38.1M0.1%−57,030−15.5%ReducedHolders
Q2 2021368,646$42.0M0.1%+55,085+17.6%AddedHolders
Q1 2021313,561$37.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.